IL159876A0 - Controlled drug delivery systems providing variable release rates - Google Patents
Controlled drug delivery systems providing variable release ratesInfo
- Publication number
- IL159876A0 IL159876A0 IL15987602A IL15987602A IL159876A0 IL 159876 A0 IL159876 A0 IL 159876A0 IL 15987602 A IL15987602 A IL 15987602A IL 15987602 A IL15987602 A IL 15987602A IL 159876 A0 IL159876 A0 IL 159876A0
- Authority
- IL
- Israel
- Prior art keywords
- drug delivery
- delivery systems
- release rates
- controlled drug
- systems providing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0117618.9A GB0117618D0 (en) | 2001-07-19 | 2001-07-19 | Pharmaceutical dosage form |
PCT/GB2002/003286 WO2003007919A1 (fr) | 2001-07-19 | 2002-07-18 | Systemes d'administration controlee de medicaments offrant des taux de liberation variables |
Publications (1)
Publication Number | Publication Date |
---|---|
IL159876A0 true IL159876A0 (en) | 2004-06-20 |
Family
ID=9918808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15987602A IL159876A0 (en) | 2001-07-19 | 2002-07-18 | Controlled drug delivery systems providing variable release rates |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060099257A1 (fr) |
EP (1) | EP1406597A1 (fr) |
JP (2) | JP2005519858A (fr) |
KR (1) | KR20040032857A (fr) |
CN (1) | CN1556697A (fr) |
AU (1) | AU2002317360B2 (fr) |
BR (1) | BR0211156A (fr) |
CA (1) | CA2457308A1 (fr) |
GB (1) | GB0117618D0 (fr) |
IL (1) | IL159876A0 (fr) |
MX (1) | MXPA04000544A (fr) |
RU (1) | RU2004104950A (fr) |
WO (1) | WO2003007919A1 (fr) |
ZA (1) | ZA200401216B (fr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003024396A2 (fr) | 2001-09-17 | 2003-03-27 | Glaxo Group Limited | Formulations de medicament en poudre seche |
UY28457A1 (es) * | 2003-08-07 | 2005-03-31 | Sb Pharmco Inc | Nueva composición |
AR046410A1 (es) | 2003-09-18 | 2005-12-07 | Cephalon Inc | Composiciones farmaceuticas para la liberacion modificada de modafinilo |
JP4919801B2 (ja) * | 2003-09-26 | 2012-04-18 | アルザ・コーポレーシヨン | 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法 |
EP1663145B1 (fr) * | 2003-09-26 | 2011-04-06 | ALZA Corporation | Baton poussoir oros pour l'administration controlee d'agents actifs |
KR20120106757A (ko) * | 2003-09-26 | 2012-09-26 | 알자 코포레이션 | 오피오이드 및 비오피오이드 진통제의 제어 방출 제제 |
NZ546183A (en) * | 2003-09-26 | 2011-04-29 | Alza Corp | Controlled release formulations exhibiting an ascending rate of release |
US7553377B1 (en) | 2004-04-27 | 2009-06-30 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for electrostatic coating of an abluminal stent surface |
US7390524B1 (en) | 2004-05-20 | 2008-06-24 | Advanced Cardiovascular Systems, Inc. | Method for electrostatic spraying of an abluminal stent surface |
JP2008509144A (ja) * | 2004-08-04 | 2008-03-27 | アルザ・コーポレーシヨン | 上昇するゼロ次放出パターンを示す持続薬剤放出組成物、そのような組成物を製造する方法 |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
PT1836665E (pt) | 2004-11-19 | 2013-04-11 | Glaxosmithkline Llc | Método para fornecimento personalizado de produtos de combinação de medicamentos em doses variáveis para individualização de terapêuticas |
US20070259930A1 (en) * | 2006-04-10 | 2007-11-08 | Knopp Neurosciences, Inc. | Compositions and methods of using r(+) pramipexole |
US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
DK2026803T3 (da) | 2006-05-16 | 2012-04-16 | Knopp Neurosciences Inc | Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf |
EP2465500A1 (fr) | 2006-05-16 | 2012-06-20 | Knopp Neurosciences, Inc. | Quantités thérapeutiquement efficaces de R(+) et S(-) pramipexole pour une utilisation dans le traitement de la maladie de Parkinson |
ES2565629T3 (es) * | 2006-05-23 | 2016-04-06 | Orahealth Corporation | Comprimido de adhesión oral bicapa con adhesivo de goma arábiga |
US8524695B2 (en) * | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
AU2008224844B2 (en) | 2007-03-14 | 2012-08-09 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
WO2009122431A2 (fr) * | 2008-02-15 | 2009-10-08 | Sun Pharma Advanced Research Company Ltd., | Comprimé oral à libération contrôlée |
TWI542338B (zh) * | 2008-05-07 | 2016-07-21 | 壯生和壯生視覺關懷公司 | 用於活性劑之控制釋放的眼用裝置 |
US8343524B2 (en) | 2008-07-31 | 2013-01-01 | Clarke Mosquito Control Products, Inc. | Extended release tablet and method for making and using same |
AU2009281537A1 (en) * | 2008-08-14 | 2011-06-30 | Bioneer A/S | Coated tablets with a remaining degradation surface over the time |
CN102186350A (zh) | 2008-08-19 | 2011-09-14 | 诺普神经科学股份有限公司 | 使用(r)-普拉克索的组合物与方法 |
TWI478712B (zh) | 2008-09-30 | 2015-04-01 | Astellas Pharma Inc | 釋控性醫藥組成物 |
US20110009460A1 (en) * | 2009-06-19 | 2011-01-13 | Valentin Gribkoff | Compositions and methods for treating amyotrophic lateral sclerosis |
US20120070465A1 (en) | 2010-03-29 | 2012-03-22 | Astellas Pharma Inc. | Pharmaceutical composition for modified release |
EP2481411A1 (fr) * | 2011-01-27 | 2012-08-01 | Ratiopharm GmbH | Formes galéniques orales pour libération modifiée comportant l'inhibiteur de JAK3 tasocitinib |
LT5850B (lt) | 2011-08-31 | 2012-07-25 | Česlovas Paplauskas | Vertikalaus srauto išorinis fazės apgręžiklis garso monitoriams |
US20130096479A1 (en) * | 2011-10-18 | 2013-04-18 | St. Teresa Medical, Inc. | Method of forming hemostatic products |
EP4035683A1 (fr) * | 2011-12-12 | 2022-08-03 | Adare Pharmaceuticals USA, Inc. | Formulations de particules à libération prolongée |
US9512096B2 (en) | 2011-12-22 | 2016-12-06 | Knopp Biosciences, LLP | Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
ES2858500T3 (es) | 2013-07-12 | 2021-09-30 | Knopp Biosciences Llc | Tratamiento de niveles elevados de eosinófilos y/o basófilos |
AU2014306683B2 (en) | 2013-08-13 | 2017-10-12 | Knopp Biosciences Llc | Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders |
HUE055850T2 (hu) | 2013-08-13 | 2022-01-28 | Knopp Biosciences Llc | Készítmények és módszerek a krónikus urticaria (csalánkiütés) kezelésére |
WO2015117004A1 (fr) * | 2014-01-31 | 2015-08-06 | Board Of Regents, The University Of Texas System | Procédé de préparation de films |
CN115645374B (zh) * | 2022-12-25 | 2024-04-26 | 山东理工职业学院 | 一种硫酸沙丁胺醇片的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8820353D0 (en) * | 1988-08-26 | 1988-09-28 | Staniforth J N | Controlled release tablet |
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
GB2253164B (en) * | 1991-02-22 | 1994-10-05 | Hoechst Uk Ltd | Improvements in or relating to electrostatic coating of substrates of medicinal products |
IT1264696B1 (it) * | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
CZ352097A3 (cs) * | 1995-05-09 | 1998-04-15 | Colorcon Limited | Způsob a materiál pro elektrostatické potahování jádra farmaceutických tablet |
OA11926A (en) * | 1999-04-13 | 2006-04-12 | Beecham Pharmacueticals Pte Lt | Novel method of treatment |
-
2001
- 2001-07-19 GB GBGB0117618.9A patent/GB0117618D0/en not_active Ceased
-
2002
- 2002-07-18 WO PCT/GB2002/003286 patent/WO2003007919A1/fr active Application Filing
- 2002-07-18 IL IL15987602A patent/IL159876A0/xx unknown
- 2002-07-18 JP JP2003513528D patent/JP2005519858A/ja active Pending
- 2002-07-18 EP EP02745646A patent/EP1406597A1/fr not_active Withdrawn
- 2002-07-18 CN CNA028184734A patent/CN1556697A/zh active Pending
- 2002-07-18 RU RU2004104950/15A patent/RU2004104950A/ru not_active Application Discontinuation
- 2002-07-18 JP JP2003513528A patent/JP2005501039A/ja active Pending
- 2002-07-18 AU AU2002317360A patent/AU2002317360B2/en not_active Ceased
- 2002-07-18 US US10/484,734 patent/US20060099257A1/en not_active Abandoned
- 2002-07-18 KR KR10-2004-7000801A patent/KR20040032857A/ko not_active Application Discontinuation
- 2002-07-18 CA CA002457308A patent/CA2457308A1/fr not_active Abandoned
- 2002-07-18 BR BR0211156-0A patent/BR0211156A/pt not_active Application Discontinuation
- 2002-07-18 MX MXPA04000544A patent/MXPA04000544A/es unknown
-
2004
- 2004-02-16 ZA ZA200401216A patent/ZA200401216B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20060099257A1 (en) | 2006-05-11 |
CA2457308A1 (fr) | 2003-01-30 |
AU2002317360B2 (en) | 2006-08-17 |
GB0117618D0 (en) | 2001-09-12 |
JP2005519858A (ja) | 2005-07-07 |
BR0211156A (pt) | 2004-08-10 |
MXPA04000544A (es) | 2005-06-06 |
JP2005501039A (ja) | 2005-01-13 |
RU2004104950A (ru) | 2005-03-10 |
WO2003007919A1 (fr) | 2003-01-30 |
CN1556697A (zh) | 2004-12-22 |
ZA200401216B (en) | 2005-03-17 |
KR20040032857A (ko) | 2004-04-17 |
EP1406597A1 (fr) | 2004-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL159876A0 (en) | Controlled drug delivery systems providing variable release rates | |
HUP0401438A3 (en) | Drug delivery system | |
HUP0500795A3 (en) | Gastric retention controlled drug delivery system | |
MXPA03009727A (es) | SISTEMA DE SUMINISTRO DE FaRMACOS DE LIBERACIoN PROLONGADA QUE CONTIENE COFARMACOS. | |
TWI350176B (en) | Controlled release delivery system for nasal applications | |
HK1077523A1 (en) | Proliposomal drug delivery system | |
EP1379291A4 (fr) | Systeme integre d'administration de medicaments | |
GB2391480B (en) | Drug delivery system | |
IL155272A0 (en) | Systems for optimized drug delivery | |
GB0123633D0 (en) | Stent delivery system | |
AU2002343555A1 (en) | Eutectic-based self-nanoemulsified drug delivery system | |
IL159875A0 (en) | Zero order controlled drug delivery system | |
EP1411905A4 (fr) | Systeme d'administration a liberation prolongee | |
AU2003288608A8 (en) | Controlled release, multiple unit drug delivery systems | |
GB0103877D0 (en) | Novel Drug Delivery system | |
MXPA03007124A (es) | Sistemas para el suministro de farmaco con objetivo anti-tumor. | |
GB0100115D0 (en) | Delivery systems | |
GB0102725D0 (en) | Medical delivery system | |
AU2002304394A1 (en) | Controlled release drug delivery device | |
AU2002246571A1 (en) | Drug delivery systems | |
GB0115136D0 (en) | Drug delivery system | |
GB0112326D0 (en) | Drug delivery system | |
AUPR567801A0 (en) | Delivery controlled systems | |
AU2002228323A1 (en) | Spaced drug delivery system | |
GB0113857D0 (en) | Delivery system |